CARE (Corona Accelerated R&D in Europe) is the largest European research initiative addressing the challenges of COVID-19. With a coalition of Europe’s best scientific minds from 37 globally-renowned research institutions and pharmaceutical companies, together with partners from the USA and China it provides a multi-disciplinary team with proven expertise and capabilities in anti-viral drug development.
Objectives & Strategy:
The CARE consortium has three main goals:
- The development of therapeutics to provide an emergency response towards the current COVID-19 pandemic
- The development of therapeutics to address the current and/or future coronavirus outbreaks
- The understanding of the physiopathology of COVID-19 and the discovery of immune markers contributing to the host immune responses to COVID-19 infection and their correlations with clinical and virological outcomes
The project ambition is to accelerate development and use of effective therapies to COVID-19 patients in Europe and around the world, and generate a truly transformative treatment regimen. The project combines a focus on rapid emergency response with focus on long-term preparedness for future outbreaks.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005077. The JU receives support from the European Union’s Horizon 2020 research and innovation programme, EFPIA, BILL & MELINDA GATES FOUNDATION, GLOBAL HEALTH DRUG DISCOVERY INSTITUTE and UNIVERSITY OF DUNDEE.
Company Details
- Founded
- -
- Address
- 51, Avenue Du Maréchal De Lattre De Tassigny, Créteil,94010,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.imi-care.eu/
- HQ
- Créteil
Care Consortium Questions
Care Consortium's website is https://www.imi-care.eu/
Care Consortium's LinkedIn profile is https://fr.linkedin.com/company/imicareconsortium
Care Consortium's industry is
Research Services
Care Consortium's top competitors are
Ai-Biopharma,
Innovative Health Initiative (Ihi),
Prv Consulting,
Mdr-Ra Project,
Epidemiology Umcg,
Ihi-Prominent,
Riders' Rights,
Fondazione O.a.s.i. - Omg Ets,
Ects Academy,
Care Consortium.
Care Consortium's categories are Research Services
Care Consortium's founding year is 2020
